Embassy Pharmaceutical AND Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Embassy Pharmaceutical AND Pharmaceutical Import Records from India — 11 Products, $14.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Embassy Pharmaceutical AND — Pharmaceutical Importer Profile (2026) | 11 Products, $14.4M Trade | TransData Nexus

Embassy Pharmaceutical AND

Pharmaceutical Importer · Nigeria · Respiratory & OTC Focus · $14.4M Total Trade · DGFT Verified

Embassy Pharmaceutical AND is a pharmaceutical importer based in Nigeria with a total trade value of $14.4M across 11 products in 6 therapeutic categories. Based on 451 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Embassy Pharmaceutical AND sources from 2 verified Indian suppliers, with Laborate Pharmaceuticals India Limited accounting for 85.1% of imports.

Embassy Pharmaceutical AND — Import Portfolio & Supplier Network

Embassy Pharmaceutical AND import network — 11 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Embassy Pharmaceutical AND?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Laborate Pharmaceuticals India Limited	$19.0M	990	85.1%
Laborate Pharmaceutical India Limited	$3.3M	141	14.9%

Embassy Pharmaceutical AND sources from across .

What Formulations Does Embassy Pharmaceutical AND Import?

Formulation	Value	Ships
1-980 kold time tablet(paracetamol BP 500MG+caffeine BP 25MG +pseudoephedrine hcl BP 30MG+chlorphenamine maleate BP 2MG)	$947.1K	21
1-980 kold time tablet (paracetamol BP	$800.0K	16
1-980 kold time tabletparacetamol BP 500MG+caffeine BP 25MG +pseudoephedrine hcl BP 30MG+chlorphenamine maleate BP 2MG	$400.0K	8
1-758 troxone forte injection	$200.0K	4
606-1426 havax forte tablet	$200.0K	4
1-300 chloramphenicol sodium succinate	$150.0K	3
1-682 havax forte tablet (artemether	$139.1K	3
1-251 reptocin-5 injection	$114.2K	3
207-368 havax tablet (artemether 20MG	$108.1K	4
1-343 kaka forte tablet (paracetamol	$107.4K	3
1-1094 fralomin tablet (sulfadoxine	$100.0K	2
1-1023 havax forte tablet (artemether	$100.0K	2
1-782 havax forte tablet (artemether	$100.0K	2
1021-1702 havax forte tablet	$100.0K	2
633-1364 havax forte tablet	$100.0K	2

Embassy Pharmaceutical AND imports 851 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 11 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Paracetamol	Analgesics & Antipyretics	$3.9M	77	1.1%	8
2	Artemether	Antimalarial & Antiparasitic	$3.2M	94	0.4%	16
3	Caffeine	Respiratory & OTC	$2.5M	75	2.4%	5
4	Ephedrine	Respiratory & OTC	$1.2M	24	5.3%	5
5	Pseudoephedrine	Respiratory & OTC	$1.2M	24	10.1%	3
6	Vati	Ayurvedic & Herbal Products	$981.3K	84	3.7%	7
7	Chloroquine	Antimalarial & Antiparasitic	$514.5K	45	0.3%	16
8	Sulfadoxine	Antimalarial & Antiparasitic	$400.0K	8	0.7%	4
9	Bromhexine	Respiratory & OTC	$195.4K	6	1.2%	11
10	Theophylline	Respiratory	$147.3K	10	0.9%	18
11	Streptomycin	Antibiotics	$127.3K	4	22.2%	2

Embassy Pharmaceutical AND imports 11 pharmaceutical products across 6 categories into Nigeria totaling $14.4M.

Embassy Pharmaceutical AND — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Embassy Pharmaceutical and Chemicals Limited, established in 1986, is a prominent pharmaceutical importer and distributor based in Lagos, Nigeria. The company is headquartered at 41 Ademola Street, Ikoyi, Lagos. It specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. Embassy Pharmaceutical and Chemicals Limited plays a significant role in Nigeria's pharmaceutical supply chain, ensuring the availability of essential medications across the country.

2Distribution Network

The company's distribution network is centered in Lagos, with its main office located at 41 Ademola Street, Ikoyi. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, Embassy Pharmaceutical and Chemicals Limited's strategic position in Lagos suggests a well-established infrastructure to support nationwide distribution. The company's operations are likely designed to ensure efficient delivery of pharmaceutical products throughout Nigeria.

3Industry Role

Embassy Pharmaceutical and Chemicals Limited functions as a primary wholesaler and importer in Nigeria's pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures a steady supply of essential medications to the Nigerian market. Its role is crucial in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, thereby contributing to the overall health infrastructure of Nigeria.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Embassy Pharmaceutical AND

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Embassy Pharmaceutical and Chemicals Limited exhibits a high degree of supplier concentration, with 85.1% of its imports sourced from Laborate Pharmaceuticals India Limited and 14.9% from Laborate Pharmaceutical India Limited. This significant reliance on a single supplier poses potential risks, such as supply chain disruptions or price fluctuations. However, the consistent volume of shipments over the years indicates a stable and long-term relationship between the company and its suppliers, suggesting that this sourcing strategy may be a deliberate choice to ensure product quality and reliability.

2Supply Chain Resilience

The resilience of Embassy Pharmaceutical and Chemicals Limited's supply chain is closely tied to its dependence on two primary suppliers in India. While this concentrated sourcing strategy may streamline operations, it also exposes the company to risks associated with geopolitical events, regulatory changes, or operational issues in India. The company's ability to diversify its supplier base and establish relationships with additional manufacturers could enhance supply chain resilience and mitigate potential disruptions.

3Strategic Implications

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) is the primary regulatory body overseeing the importation, distribution, and marketing of pharmaceutical products. NAFDAC ensures that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are allowed into the Nigerian market. The agency enforces regulations that govern the importation process, including the registration of pharmaceutical products and the issuance of import permits.

2Import Licensing & GMP

Importers of pharmaceutical products into Nigeria must obtain the necessary import licenses from NAFDAC. These licenses are granted based on the submission of comprehensive documentation, including certificates of Good Manufacturing Practice (GMP) from the exporting country. NAFDAC recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must also ensure that their suppliers hold valid GMP certificates to comply with Nigerian regulations.

3Quality & Labeling

Embassy Pharmaceutical AND — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Embassy Pharmaceutical and Chemicals Limited's focus on importing products in the Respiratory & OTC, Antimalarial & Antiparasitic, and Analgesics & Antipyretics categories aligns with the prevalent health challenges in Nigeria. The high import values of Paracetamol, Artemether, Caffeine, Ephedrine, and Pseudoephedrine indicate a strategic emphasis on addressing common ailments such as pain, fever, respiratory issues, and malaria. This product strategy is driven by the substantial market demand for these medications, reflecting the company's commitment to meeting the healthcare needs of the Nigerian population.

2Sourcing Profile

Embassy Pharmaceutical and Chemicals Limited's sourcing strategy is heavily reliant on generic drug formulations, primarily imported from India. The company's preference for finished pharmaceutical formulations over raw Active Pharmaceutical Ingredients (APIs) suggests a focus on ready-to-market products that can be quickly distributed to meet local demand. India's well-established pharmaceutical manufacturing industry, recognized for its adherence to international quality standards, makes it a preferred sourcing destination for the company.

3Market Positioning

Seller's Guide — How to Become a Supplier to Embassy Pharmaceutical AND

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by partnering with Embassy Pharmaceutical and Chemicals Limited. The company's concentrated sourcing pattern indicates potential gaps that alternative suppliers could fill, especially if they can offer competitive pricing, consistent product quality, and reliable delivery schedules. Establishing a partnership with Embassy Pharmaceutical and Chemicals Limited could provide Indian exporters with a strategic entry point into the Nigerian pharmaceutical market.

2Requirements & Qualifications

Indian exporters seeking to supply Embassy Pharmaceutical and Chemicals Limited must ensure that their products are registered with NAFDAC and comply with Nigerian pharmaceutical regulations. They must provide valid GMP certificates recognized by NAFDAC, such as those from WHO or PIC/S. Additionally, exporters should ensure that their products meet the quality control standards required by NAFDAC, including batch testing and stability studies.

3How to Approach

Frequently Asked Questions — Embassy Pharmaceutical AND

What products does Embassy Pharmaceutical AND import from India?

Embassy Pharmaceutical AND imports 11 pharmaceutical products across 6 categories. Top imports: Paracetamol ($3.9M), Artemether ($3.2M), Caffeine ($2.5M), Ephedrine ($1.2M), Pseudoephedrine ($1.2M).

Who supplies pharmaceuticals to Embassy Pharmaceutical AND from India?

Embassy Pharmaceutical AND sources from 2 verified Indian suppliers. The primary supplier is Laborate Pharmaceuticals India Limited (85.1% of imports, $19.0M).

What is Embassy Pharmaceutical AND's total pharmaceutical import value?

Embassy Pharmaceutical AND's total pharmaceutical import value from India is $14.4M, based on 451 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Embassy Pharmaceutical AND focus on?

Embassy Pharmaceutical AND imports across 6 categories. The largest: Respiratory & OTC (35.7%), Antimalarial & Antiparasitic (28.8%), Analgesics & Antipyretics (26.8%).

Get Full Embassy Pharmaceutical AND Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.